Thrombolytic Therapy in Acute Ischemic Stroke III

Front Matter....Pages II-XV
Front Matter....Pages 1-1
Time Course of Leukocyte Influx Following Middle Cerebral Artery Occlusion in the Wistar Rat....Pages 3-9
The Role of P-Selectin and ICAM-1 During Focal Brain Ischemia/Reperfusion....Pages 10-18
Delayed Neuronal Death and Ischemic Tolerance....Pages 19-28
Positron Emission Tomography in Patients with an Acute Embolic Occlusion of the Carotid Artery....Pages 29-36
Front Matter....Pages 39-39
Early Findings of Computed Tomography and Angiography in Acute Stroke and Thrombolytic Therapy....Pages 41-46
Role of Extracranial Ultrasound and Angioscopy in Thrombolytic Therapy....Pages 47-55
Transcranial Contrast-Enhanced Color-Flow Imaging....Pages 56-60
Value of Single Photon Emission Computed Tomography in Acute Stroke Therapeutic Trials....Pages 61-71
Correlation of SPECT with Angiography in Early Ischemic Stroke....Pages 72-80
New MR Technologies for Diagnosis of Acute Ischemic Stroke: MR Angiography, Diffusion, and Perfusion Imaging....Pages 81-85
Front Matter....Pages 39-39
Behavioral Syndromes in Early Right Middle Cerebral Artery Territory Stroke....Pages 93-98
Symptoms and Signs in Early Vertebrobasilar Territory Stroke....Pages 99-106
Subtypes of Infarction and Their Differentiation: Relevance to Thrombolytic Therapy and Early Randomization....Pages 107-109
Front Matter....Pages 113-113
Applications of Diffusion-Weighted Magnetic Resonance Imaging for Stroke Diagnosis and Treatment....Pages 115-123
Strategies of Early Patient Recruitment: A Community-Based Study....Pages 124-129
Neuro-Intensive Care Units and Management of Acute Stroke Patients: Benefits and Limitations....Pages 130-140
Brain-Oriented Intensive Care: Standardization of Postresuscitation Therapy....Pages 141-151
Meta-Analysis of Data from Trials of Thrombolytic Therapy in Acute Ischemic Stroke....Pages 152-158
Front Matter....Pages 163-163
Thrombolytic Therapy in Acute Ischemic Stroke: Combination Therapy with Antiplatelet and Anticoagulant Agents....Pages 165-173
Combination Therapy with Cytoprotective Agents....Pages 174-181
Front Matter....Pages 163-163
New Thrombolytic Agents: Basic Development....Pages 182-187
Front Matter....Pages 191-191
The NINDS t-PA Stroke Trial: Progress Report....Pages 193-197
Is Thrombolysis Useful for Acute Stroke Patients? The Experience of the MAST-I Study....Pages 198-205
The Multicenter Acute Stroke Trial (MAST)—Thrombolysis Study: Study Design and Progress Report....Pages 206-213
Australian Streptokinase Trial: Progress Report....Pages 214-217
European Cooperative Acute Stroke Study: Trial Protocol....Pages 218-222
Clinical Efficacy and Safety of Intravenous Tissue Plasminogen Activator in Acute Embolic Stroke: A Randomized, Double-Blind, Dose-Comparison Study of Duteplase....Pages 223-229
Front Matter....Pages 233-233
Delayed Recanalization and Reocclusion Following Thrombolysis for Acute Stroke....Pages 235-241
Intracranial Hemorrhage in Association with Thrombolysis: Multiple Causes and Risk Factors (No Simple Answer)....Pages 242-253
Mechanisms of Fibrinolysis-Associated Hemorrhagic Transformation....Pages 254-266
Front Matter....Pages 233-233
Plasminogen Plus rt-PA Improves Intraarterial Thrombolytic Therapy in Acute Ischemic Stroke....Pages 271-278
Intraarterial Therapy in Acute Ischemic Stroke....Pages 279-287
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke....Pages 288-293
Interventional Neurovascular Techniques in Acute Thrombolytic Therapy for Stroke....Pages 294-300
“Central” Intraarterial Thrombolysis Using a Newly Developed Low Friction Guidewire/Catheter System....Pages 301-306
Front Matter....Pages 309-309
Microvascular Leukocyte Plugging in Evolving Brain Infarction in Humans....Pages 311-314
Recombinant Tissue Plasminogen Activator and Mutant rt-PA: Binding Kinetics and Cytotoxicity on Brain Endothelial Cells—Relevance to Brain Hemorrhage....Pages 315-322
Reperfusion in Patients with the “Spectacular Shrinking Deficit” Demonstrated by 99m Tc-hexamethylpropyleneamine Oxime Single Photon Emission Computed Tomography....Pages 323-326
Reliability of the Barthel Index Outcome Measure Selected for the NINDS t-PA Stroke Trial....Pages 327-334
Acute Local Fibrinolysis for Embolic Middle Cerebral Artery Occlusion Using Recombinant Tissue Type Plasminogen Activator....Pages 335-338
Front Matter....Pages 309-309
Intracarotid Recombinant Tissue Plasminogen Activator in Acute Carotid Artery Territory Stroke....Pages 339-342
Thrombolytic Therapy of Basilar Artery Occlusion: Preconditions for Recanalization and Good Clinical Outcome....Pages 343-348
Back Matter....Pages 355-357